Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of plecanatide pills in China. Welcome to wholesale bulk high quality plecanatide pills for sale here from our factory. Good service and reasonable price are available.
Upon binding to specific targets on the cell surface, plecanatide pills efficiently catalyzes the conversion of intracellular guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP), leading to a marked elevation in intracellular cGMP levels. As a crucial intracellular signaling molecule, cGMP directly activates specific chloride channels on the cell membrane, disrupting the steady-state balance of chloride ions between the intracellular and extracellular spaces. Once activated, these chloride channels selectively allow the efflux of intracellular chloride ions (Cl⁻) to the extracellular space. At this point, the intracellular chloride ion concentration is higher than the extracellular level, and a certain potential difference exists across the cell membrane. Driven by both the concentration gradient and electrochemical gradient, chloride ions are secreted from the cell to the extracellular region in large quantities and at a rapid rate. This process serves as the initial step of the entire secretory cascade and lays the foundation for subsequent ion and water transport.
Our products From
 |
 |
 |
Plecanatide COA
Plecanatide benefits users by softening feces and improving quality of life
Plecanatide pills exerts its stool-softening effect primarily by catalyzing an increase in intracellular cyclic guanosine monophosphate (cGMP) levels, which triggers a series of ion transport processes, ultimately promoting the transfer of water out of cells to hydrate the stool. This mechanism can be divided into three key steps, focusing on the transport patterns of ions such as chloride and sodium, as explained in detail below:
When Plecanatide binds to specific targets on the cell surface, it efficiently catalyzes the conversion of intracellular guanosine triphosphate (GTP) into cyclic guanosine monophosphate (cGMP), leading to a significant increase in intracellular cGMP concentration. As a key intracellular signaling molecule, cGMP directly activates specific chloride channels on the cell membrane, disrupting the homeostatic balance of chloride ions inside and outside the cell.
Upon activation, these chloride channels selectively allow intracellular chloride ions (Cl⁻) to flow outward. At this stage, the intracellular chloride ion concentration is higher than the extracellular concentration, and a certain membrane potential difference exists. Driven by both concentration and electrochemical gradients, chloride ions are secreted in large quantities and rapidly from the cell into the extracellular space. This marks the initial step of the entire secretion-promoting process and serves as the foundation for subsequent ion and water transport.
2. Outward Flow of Chloride Ions Drives Passive Transport of Sodium Ions, Maintaining Electrochemical Balance
Chloride ions (Cl⁻) carry a negative charge. When they flow outward in large quantities, the concentration of negative charges in the extracellular region significantly increases, disrupting the electrochemical balance between the inside and outside of the cell. According to the principle of electrochemical balance, negatively charged chloride ions exert an electrostatic attraction on surrounding positively charged ions. The most abundant and mobile positively charged ions in the extracellular environment are sodium ions (Na⁺).
To maintain electrochemical neutrality inside and outside the cell, sodium ions (Na⁺) attracted by chloride ions passively follow the flow of chloride ions, moving from the intracellular to the extracellular space. This transport process does not require cellular energy consumption and is classified as passive transport. Its rate and magnitude directly depend on the intensity of chloride ion outflow-the greater the secretion of chloride ions, the larger the passive transport of sodium ions. Ultimately, this leads to the simultaneous accumulation of chloride and sodium ions in the extracellular region, altering the osmotic pressure balance between the intracellular and extracellular environments.
3. Ion Accumulation Drives Passive Water Penetration, Hydrating Stool for Softening
As chloride ions (Cl⁻) and sodium ions (Na⁺) accumulate in large quantities in the extracellular region, the total ion concentration outside the cell becomes significantly higher than inside, creating a distinct osmotic pressure gradient. The movement of water consistently follows the principle of osmosis, flowing from areas of low osmotic pressure to areas of high osmotic pressure. Therefore, intracellular water (H₂O) passively crosses the cell membrane and moves toward the extracellular region of higher osmotic pressure to mitigate the osmotic pressure difference between the inside and outside of the cell.
After a substantial amount of water is transferred to the extracellular space, it thoroughly hydrates the surrounding stool, gradually reducing its hardness and viscosity. Initially dry and dense stool becomes looser and more fluid as its fibrous structure is adequately hydrated. This softens the stool, making it easier to pass. Throughout this process, the activation and outward flow of chloride ions serve as the core driving force, the passive transport of sodium ions is key to maintaining electrochemical balance, and the penetration of water is the direct mechanism for achieving stool softening.
This process primarily occurs at the cellular level and relies on ion channels and transport mechanisms on the cell membrane. It does not depend on specialized regulation by intestinal structures, further highlighting Plecanatide's characteristic of acting locally at the cellular level.
Plecanatide core advantage: the drug does not invade the whole body
Plecanatide pills is a linear polypeptide formed by the ordered linkage of 16 amino acid residues. Its molecular weight and spatial dimensions far exceed those of small-molecule chemical drugs like aspirin. Typically, the molecular diameter of such small-molecule drugs is less than 1 nm, enabling transmembrane diffusion through the tight junction spaces between cells. In contrast, the spatial diameter of the intact plecanatide molecule, composed of 16 amino acid residues, significantly surpasses the pore size threshold of intercellular tight junctions, making it difficult to traverse this physical barrier between cells.
The molecular structure of plecanatide contains multiple disulfide bonds. These covalent cross-links not only promote specific folding of the polypeptide chain, forming a stable and rigid three-dimensional spatial conformation to maintain the structural basis for target binding, but also substantially enhance the molecule's hydrophilicity.
From a cellular perspective, the core structure of the cell membrane is a lipid bilayer. Its interior consists of a dense hydrophobic core region formed by hydrophobic fatty acid chains, while hydrophilic groups are distributed on the inner and outer surfaces of the bilayer. According to the fundamental physicochemical principle of "like dissolves like," highly hydrophilic macromolecules struggle to dissolve within the hydrophobic core of the cell membrane, preventing passive diffusion across it.
Furthermore, cell surfaces possess very few specific active transport carriers for polypeptide substances. Moreover, the substrates for such carriers are typically short peptide fragments composed of 2-3 amino acids, not long-chain polypeptides like the 16-amino-acid plecanatide. As a result, plecanatide exhibits extremely low binding affinity for these carriers, precluding substantial cellular uptake via active transport pathways.
Multiple Cellular Absorption Barriers Further Limit Drug Permeability
The cell surface is covered by a mucus layer formed by the polymerization of mucin proteins. Mucin molecules bear numerous glycosylation modification groups, which confer the mucus layer with strong hydrophilicity and high-viscosity gel-like properties. When plecanatide approaches the cells, this gel-like mucus layer exerts significant physical entrapment on large polypeptide molecules. This not only delays the contact time between the drug and the cell membrane surface but also substantially reduces the effective contact area between the drug and the cell membrane, further hindering the drug's penetration into the cells.
From the perspective of cell membrane composition and function, the apical membrane of cells is primarily structured around a phospholipid bilayer. Its lipid components are predominantly composed of long-chain fatty acids, and it lacks specific carrier proteins capable of efficiently recognizing and transporting long-chain polypeptides. Even if plecanatide manages to bypass the obstruction of the mucus layer and reach the cell membrane surface, it cannot effectively bind to transport carriers on the apical membrane. Consequently, it is difficult for cells to take up the drug via endocytosis, let alone penetrate the hydrophobic core region of the cell membrane to enter the intracellular environment. As a result, the drug cannot further enter the bloodstream to exert its therapeutic effects.
Numerous peptidases with high catalytic activity, including various types such as aminopeptidases, carboxypeptidases, and endopeptidases, are widely distributed in the brush border region of the cell surface and the surrounding microenvironment. These peptidases are key functional molecules in cell-mediated metabolism of polypeptide and protein substances. Among them, aminopeptidases can gradually hydrolyze amino acid residues from the amino terminus of a polypeptide chain, carboxypeptidases cleave from the carboxyl terminus, and endopeptidases directly recognize and cleave specific peptide bond sites within the polypeptide chain.
As an exogenous long-chain polypeptide, plecanatide's molecular structure contains multiple specific cleavage sites for precisely these types of peptidases. Upon contact with cell-associated peptidases, plecanatide pills is rapidly recognized and hydrolyzed, breaking down into a series of small peptide fragments or free amino acids.
It is crucial to emphasize that the pharmacological activity of plecanatide is highly dependent on its intact 16-amino-acid peptide chain structure and its specific spatial conformation. The small peptide fragments or amino acids produced by hydrolysis lose the structural basis for binding to the target receptor and do not possess the biological activity of the original drug. Even if these degradation products are absorbed by cells in small quantities, they cannot exert the drug's pharmacological effects. Consequently, this process significantly reduces the proportion of the prototype drug that enters the systemic circulation.
Hot Tags: plecanatide pills, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale